Keynote Speaker for this Event: Ana T. Menendez, Ph.D., Senior Director of BioTechnology, Catalent Pharma Solutions

Sponsored by:

Biopharmaceutical products hold great promise in therapeutics because of their excellent targeting ability.

This advantage is tempered with the danger of inducing an unwanted immune response in patients. Various external (i.e., patient population, disease indication, dose of administration, etc.) and internal factors (i.e., glycosylation patterns, aggregation, formulation, etc.) can have a significant impact on the immunogenic response of a biopharmaceutical.

All biopharmaceutical development programs need to quickly identify and characterize antibodies that can affect the potency and safety of the drug. Appropriate interpretation of industry expectations and regulatory documents regarding immunogenicity is required to successfully plan a productive immunogenicity program. A clear strategic path to evaluate risk and manage immunogenicity issues is essential to not only be successful in the clinic but also throughout the entire life cycle of a drug.

• This webinar first describes how to differentiate the risk associated with internal attributes of the drug from the risk derived from external factors.
• The second section provides a guideline for selecting the best methods to analyze and characterize antibodies.
• The presentation finishes with recommendations on a risk-based sampling strategy and representative clinical case studies describing the importance of immunogenicity testing not only during clinical trials but also after the drug is commercialized.

Access to this archive is given on the understanding that you agree to the provision of your contact information to Xtalks sponsors and partners. Only primary contact information will be shared and this information will only be shared for the purposes of providing relevant offers. This registration form is an application only. Xtalks has the right to refuse access.

If you require help with your registration or have any questions you may contact Xtalks at: email: register@xtalks.com; phone: 416-977-6555, x 371.

By completing this registration form, you agree that the information you have provided is true and accurate.

(note: fields with marked "*" are required)